Existing research - HRT For Menopause

Based on the current medical consensus as of early 2026, here is the breakdown of the pros and cons of Hormone Replacement Therapy (HRT).

The “Big Study” (WHI) panic of 2002 has largely been replaced by a nuanced understanding that risk depends heavily on:

the type (synthetic vs. body-identical),
route (pill vs. patch), and
**timing** (age).

The Bottom Line Up Front

For most healthy women under 60 or within 10 years of menopause, the benefits of modern HRT generally outweigh the risks. The “cons” listed below are often specific to older forms of HRT (tablets) or long-term use (>10 years).

The Pros (Benefits)

HRT remains the most effective treatment for menopausal symptoms and offers significant long-term preventative health benefits.

Immediate Symptom Control

* Vasomotor Symptoms: It effectively eliminates or significantly reduces hot flushes and night sweats in roughly 90% of women.

* Genitourinary Health: It reverses vaginal dryness, soreness, and painful intercourse (Genitourinary Syndrome of Menopause) and reduces the frequency of recurrent urinary tract infections (UTIs).

* Mood & Sleep: By stabilising hormone fluctuations, it often improves sleep quality and stabilises low mood or anxiety associated with menopause.

Long-Term Health Protection

* Bone Health (Osteoporosis): Estrogen is crucial for bone density. HRT significantly reduces the risk of fractures (hip and spine) while taken. It is often the first-line treatment for preventing osteoporosis in women with early menopause.

* Heart Health (The “Timing Hypothesis”): If started early (within 10 years of menopause), estrogen helps keep arteries flexible and may reduce the risk of heart disease and mortality by roughly 30%.

* Diabetes Prevention: HRT improves insulin sensitivity and lowers the risk of developing Type 2 diabetes.

* Colorectal Cancer: Combined HRT (estrogen + progestogen) has been associated with a reduced risk of bowel cancer.

The Cons (Risks)

These risks are real but often overstated. They are heavily dependent on *how* the hormone is taken.

Breast Cancer Risk (The Main Concern)

* The Nuance: The risk is primarily linked to **Combined HRT** (Estrogen + Progesterone).

* Estrogen-Only: Women who have had a hysterectomy and take Estrogen-only HRT have little to no increased risk of breast cancer.

* Combined HRT Statistics: For women taking Combined HRT for 5 years, there are approximately 4 extra cases of breast cancer per 1,000 women. (For context: obesity causes ~24 extra cases per 1,000 women).

* Modern Progesterone: The risk appears lower with “micronised progesterone” (body-identical) compared to older synthetic progestins.

Blood Clots & Stroke

* Oral Tablets: Taking estrogen as a pill increases the risk of blood clots (DVT) and stroke because it is processed by the liver, which increases clotting factors.

* Transdermal (Patches/Gels/Sprays): This is a critical distinction. Absorbing estrogen through the skin does not increase the risk of blood clots or stroke. It is risk-neutral.

Other Risks

* Ovarian Cancer: There is a tiny associated risk (approx. 1 extra case per 1,000 users over 5 years).

* Endometrial Cancer: If a woman with a womb takes Estrogen without Progesterone, the lining of the womb can thicken and become cancerous. Taking Progesterone alongside Estrogen neutralizes this risk.

* Gallbladder Disease: Oral estrogen increases the risk of gallstones; transdermal routes generally do not.

The “Grey Area” (Neither Pro nor Con)

* Dementia: The 2026 consensus is that HRT is likely **neutral** for dementia risk. It is not a cure to prevent Alzheimer’s, but it does not cause it if started early. However, starting HRT late (after age 65) may slightly increase dementia risk.

* Weight Gain: Despite common belief, clinical trials generally show HRT does **not** cause weight gain. It may actually help prevent the accumulation of abdominal (visceral) fat.